Exhibit 5.2

Lilium N.V. Galileostraße 335 82131 Gauting, Germany
	New York
	3 World Trade Center
	175 Greenwich Street, 51st Floor
	New York, NY 10007
	T +1 (212) 277-4000
	www.freshfields.com

July 29, 2024

Ladies and Gentlemen:

We are acting as United States counsel to Lilium N.V., a Dutch public limited liability company (the Company), in connection with the registration statement on Form F-3 filed with the U.S. Securities and Exchange Commission (the Commission) on July 29, 2024 (as it may be amended and supplemented after the initial filing date, the Registration Statement, which term does not include any other document or agreement whether or not specifically referred to therein or attached as an exhibit or schedule thereto), relating to the registration under the U.S. Securities Act of 1933, as amended (the Securities Act), of (i) 94,710,972 class A ordinary shares, nominal value €0.01 per share (the Class A Shares and, the registered Class A Shares, the Shares), which consists of (a) 21,830,278 Class A Shares and 21,830,278 Class A Shares issuable upon exercise of warrants (the Offered PIPE Warrants), in each case, sold by the Company pursuant to the securities purchase agreement dated May 23, 2024 by and among the Company and the investors named therein (the Securities Purchase Agreement), (b) 24,025,208 Class A Shares issuable upon exercise of a partially pre-funded warrant (the Pre-Funded Warrant) and 24,025,208 Class A Shares issuable upon exercise of a warrant (the Accompanying Warrant and, collectively with the Offered PIPE Warrants and the Pre-Funded Warrant, the Warrants), in each case issued by the Company pursuant to the securities purchase agreement dated May 23, 2024 by and between the Company and the applicable investor named therein (the Pre-Funded Warrant Purchase Agreement), and (c) 3,000,000 Class A Shares issued by the Company pursuant to the Share Issuance Agreement dated June 18, 2024 by and between the Company and the applicable investor named therein (the Share Issuance Agreement, collectively with the Securities Purchase Agreement and the Pre-Funded Warrant Purchase Agreement, the Agreements), and (ii) the Warrants.

The opinion expressed herein is confined to the law of the State of New York, as currently in effect. Accordingly, we express no opinion herein with regard to any other laws. The opinion expressed herein is limited to the matters stated herein, and no opinion is implied or may be inferred beyond the matters expressly stated herein. We do not undertake to advise you of changes in law or facts that may come to our attention after the date of this letter.

Insofar as the opinion expressed herein relates to or is dependent upon matters governed by the law of The Netherlands, we have relied upon the opinion dated on or about the date hereof of Freshfields Bruckhaus Deringer LLP, which opinion is being filed as an exhibit to the Registration Statement.

In rendering the opinion expressed below, we have examined the following documents and agreements:

(a) the Securities Purchase Agreement and the form of Offered PIPE Warrant attached thereto (the Form of PIPE Warrant);

Freshfields Bruckhaus Deringer is an international legal practice operating through Freshfields Bruckhaus Deringer US LLP, Freshfields Bruckhaus Deringer LLP, Freshfields Bruckhaus Deringer (a partnership registered in Hong Kong), Freshfields Bruckhaus Deringer Law office, Freshfields Bruckhaus Deringer Foreign Law Office, Studio Legale associato a Freshfields Bruckhaus Deringer, Freshfields Bruckhaus Deringer Rechtsanwälte Steuerberater PartG mbB, Freshfields Bruckhaus Deringer Rechtsanwälte PartG mbB and other associated entities and undertakings. For further regulatory information please refer to www.freshfields.com/support/legal-notice.

2 | 3

(b) the Pre-Funded Warrant Purchase Agreement and the form of Pre-Funded Warrant attached thereto (the Form of Pre-Funded Warrant);

(c) the warrant agreement, dated as of May 31, 2024, pursuant to which the Offered PIPE Warrants and the Accompanying Warrant were issued (the PIPE Warrant Agreement and, together with the Form of PIPE Warrant, the PIPE Warrant Documents), by and between the Company and Continental Stock Transfer & Trust Company (Continental);

(d) the warrant agreement, dated as of June 28, 2024 (the Pre-Funded Warrant Agreement and, collectively with the Form of Pre-Funded Warrant and the PIPE Warrant Documents, the Warrant Documents), by and between the Company and Continental; and

(e) the Registration Statement.

In addition, we have examined and have relied as to matters of fact upon such corporate and other records, agreements, documents and other instruments and certificates or comparable documents of public officials and of officers and representatives of the Company and such other persons, and we have made such other investigations, as we have deemed relevant and necessary as a basis for the opinion expressed below.

In our examination, we have assumed the genuineness of all signatures, the legal capacity of natural persons, the authenticity of all documents submitted to us as originals and the conformity with authentic originals of all documents submitted to us as copies. As to any facts material to the opinion expressed herein that we did not independently establish or verify, we have relied, without independent verification, upon the representations and warranties contained in the Agreements, and oral or written statements and representations of public officials, officers and other representatives of the Company. We have also assumed that the Warrant Documents have been duly authorized, executed and delivered by the parties thereto.

Based upon the foregoing, and subject to the limitations, qualifications and assumptions set forth herein, we are of the opinion that, assuming that (i)the Warrants have been duly authorized by the Company, and (ii) the PIPE Warrant Agreement and the Pre-Funded Warrant Agreement have been duly authorized, executed and delivered by the Company and constitute valid and legally binding obligations of Continental, the PIPE Warrant Agreement, the Pre-Funded Warrant Agreement and the Warrants constitute valid and legally binding obligations of the Company, enforceable against the Company in accordance with their terms.

Our opinion above is subject to (i) (a) the effects of bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or transfer or other similar laws relating to or affecting the rights of creditors generally, (b) the possible judicial application of foreign laws or governmental action affecting the rights of creditors generally and (c) the application of general principles of equity (regardless of whether considered in a proceeding in equity or at law), including without limitation (1) the possible unavailability of specific performance, injunctive relief or any other equitable remedy and (2) concepts of materiality, reasonableness, good faith and fair dealing, and (ii) limitations on the right to indemnity and contribution under applicable law and public policy.

In addition, we express no opinion as to (i) the validity, legally binding effect or enforceability of (a) any waiver of immunity, (b) any waiver of a right to trial by jury, (c) any waiver of inconvenient forum set forth in the Warrant Documents and the Warrants or (d) any provisions relating to partial unenforceability contained in the Warrant Documents or (ii) (a) whether a federal or state court outside New York would give effect to any choice of law provided for in the Warrant Documents and the Warrants or (b) any provisions of the Warrant Documents and the Warrants that relate to the subject matter jurisdiction of the federal or state courts of a particular jurisdiction to adjudicate any controversy related to the Warrant Documents and the Warrants or the transactions contemplated thereby.

The opinion expressed in this letter is solely for your benefit and the benefit of persons entitled to rely thereon pursuant to applicable provisions of the Securities Act and the rules and regulations of the Commission promulgated thereunder, in connection with the Registration Statement, and may not be relied upon in any manner or used for any purpose by any other person or entity.

 

3 | 3

We hereby consent to the filing of this opinion letter with the Commission as Exhibit 5.2 to the Registration Statement and further consent to the reference to our name under the caption “Legal Matters” in the prospectus which is a part of the Registration Statement. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act.

Very truly yours,

/s/ Freshfields Bruckhaus Deringer US LLP